- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 8th, 2007
Jeff Williams has no illusions about why he was appointed chief executive of Platypus Technologies. His mission, and the company's mission, is to start actively commercializing the combination "bio" and "nano" technology that has been under development inside its New Venture Center facility.
Platypus, which helps researchers study chemical reactions with the help of nano-structured surfaces, is closer to launching a key assay, and Williams has ample experience bringing products to market at career stops like Roche Diagnostics and Ambion Diagnostics, where he was responsible for the commercialization of several FDA-regulated products.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Promising Step Taken in Iran towards Treatment of Spinal Cord Injury August 3rd, 2015
Kalam: versatility personified August 1st, 2015
BESSTECH Names Doug Grose as Chief Technology Officer: Former GLOBALFOUNDRIES CEO to drive technology roadmap and strategic partnerships for emerging lithium-ion battery component company July 14th, 2015
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015
New computer model could explain how simple molecules took first step toward life: Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules July 28th, 2015
Spintronics: Molecules stabilizing magnetism: Organic molecules fixing the magnetic orientation of a cobalt surface/ building block for a compact and low-cost storage technology/ publication in Nature Materials July 25th, 2015